Qualigen Therapeutics, Inc. (NASDAQ:QLGN – Get Free Report) was the target of a significant drop in short interest during the month of February. As of February 28th, there was short interest totalling 75,300 shares, a drop of 15.3% from the February 13th total of 88,900 shares. Based on an average trading volume of 49,500 shares, the short-interest ratio is presently 1.5 days. Currently, 11.0% of the company’s shares are sold short.
Qualigen Therapeutics Trading Up 1.3 %
Qualigen Therapeutics stock opened at $3.10 on Tuesday. The business’s 50-day simple moving average is $3.55 and its 200 day simple moving average is $5.23. Qualigen Therapeutics has a 12-month low of $2.96 and a 12-month high of $29.44.
Qualigen Therapeutics Company Profile
Recommended Stories
- Five stocks we like better than Qualigen Therapeutics
- Find and Profitably Trade Stocks at 52-Week Lows
- Can TikTok Stock Picks Really Make You Rich?
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- The “Quality” Rotation: Back to Basics Investing
- What is diluted earnings per share (Diluted EPS)?
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Qualigen Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Qualigen Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.